Successful transition to mirikizumab following hepatic abscess during adalimumab therapy in a patient with ulcerative colitis
{{output}}
Ulcerative colitis (UC) is associated with an increased risk of infectious complications, particularly during anti-tumor necrosis factor (anti-TNF) therapy. Pyogenic hepatic abscess is a rare but potentially life-threatening extraintestinal complication of UC.... ...
